Jay M. Moyes, Chief Financial Officer at MYRIAD GENETICS INC (MYGN), sold 5,931 shares at $55.24 ($327K) on 2007-10-15, disclosed to the SEC on 2007-10-16.
Scheduled sale ($327k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.13 | 1,505 | $83K | 25.3% |
| 2 | $55.14 | 430 | $24K | 7.2% |
| 3 | $55.15 | 263 | $15K | 4.4% |
| 4 | $55.17 | 401 | $22K | 6.8% |
| 5 | $55.18 | 86 | $5K | 1.4% |
| 6 | $55.19 | 344 |
| $19K |
| 5.8% |
| 7 | $55.20 | 86 | $5K | 1.5% |
| 8 | $55.21 | 516 | $28K | 8.7% |
| 9 | $55.23 | 172 | $9K | 2.9% |
| 10 | $55.24 | 86 | $5K | 1.5% |
| 11 | $55.25 | 860 | $48K | 14.5% |
| 12 | $55.26 | 774 | $43K | 13.1% |
| 13 | $55.27 | 86 | $5K | 1.5% |
| 14 | $55.31 | 258 | $14K | 4.4% |
| 15 | $55.32 | 64 | $4K | 1.1% |
| Total | $55.20 avg | 5,931 | $327K | 100% |
| Filing → |
| SINT | BUY | 2025-08-27 | $11K | — | Filing → |
| PBYI | SELL | 2025-06-17 | $75K | — | Filing → |
| PBYI | SELL | 2024-06-17 | $73K | — | Filing → |